Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ANRG -- Anergen -- new CEO big chance ? -- Ignore unavailable to you. Want to Upgrade?

To: bob jaremsek who wrote (81)	4/13/1998 5:14:00 PM
From: Marvin Frank	Read Replies (1) \| Respond to of 123

Has anyone read the 1997 Report for one of the most exciting reports on new product called DIAVAX. Preliminary animal tests showed that DIAVAX was able to act as a vaccine to prevent or delay the onset of type 1 diabetes in 75% of animals. This is a first for me and a great advance for any vaccine; even if only preliminary/ Too bad Anergen does not have enough funds to press forward on necessary research. Perhaps their partner will assist even more.